Login / Signup

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases.

Dana KablawiFaisal AljohaniChiara Saroli PalumboSophie RestelliniAlain BittonGary WildWaqqas AfifPeter L LakatosTalat BessissowGiada Sebastiani
Published in: Crohn's & colitis 360 (2023)
Assessment of cardiovascular risk should be targeted in IBD patients with NAFLD, particularly if they have longer IBD duration and ulcerative colitis.
Keyphrases
  • ulcerative colitis
  • cancer therapy
  • liver fibrosis
  • drug delivery